These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25499129)

  • 1. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.
    Capoulade R; Mahmut A; Tastet L; Arsenault M; Bédard É; Dumesnil JG; Després JP; Larose É; Arsenault BJ; Bossé Y; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):26-33. PubMed ID: 25499129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.
    Tastet L; Capoulade R; Shen M; Clavel MA; Côté N; Mathieu P; Arsenault M; Bédard É; Tremblay A; Samson M; Bossé Y; Dumesnil JG; Arsenault BJ; Beaudoin J; Bernier M; Després JP; Pibarot P
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
    Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
    J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.
    Capoulade R; Yeang C; Chan KL; Pibarot P; Tsimikas S
    JAMA Cardiol; 2018 Dec; 3(12):1212-1217. PubMed ID: 30476957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
    Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
    Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Lp-PLA2 is associated with high valvuloarterial impedance and low arterial compliance in patients with aortic valve bioprostheses.
    Mahmut A; Mahjoub H; Boulanger MC; Dahou A; Bouchareb R; Capoulade R; Arsenault BJ; Larose E; Bossé Y; Pibarot P; Mathieu P
    Clin Chim Acta; 2016 Apr; 455():20-5. PubMed ID: 26797670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.
    Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A
    Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
    J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lp-PLA2 is associated with structural valve degeneration of bioprostheses.
    Mahmut A; Mahjoub H; Boulanger MC; Fournier D; Després JP; Pibarot P; Mathieu P
    Eur J Clin Invest; 2014 Feb; 44(2):136-45. PubMed ID: 24328921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and immune complexes to oxidation-specific epitopes and progression of aortic stenosis: Results from the ASTRONOMER trial.
    Capoulade R; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    Atherosclerosis; 2017 May; 260():1-7. PubMed ID: 28319871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study.
    Tastet L; Capoulade R; Clavel MA; Larose É; Shen M; Dahou A; Arsenault M; Mathieu P; Bédard É; Dumesnil JG; Tremblay A; Bossé Y; Després JP; Pibarot P
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):70-78. PubMed ID: 26896413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcific Aortic Valve Stenosis and Atherosclerotic Calcification.
    de Oliveira Sá MPB; Cavalcanti LRP; Perazzo ÁM; Gomes RAF; Clavel MA; Pibarot P; Biondi-Zoccai G; Zhigalov K; Weymann A; Ruhparwar A; Lima RC
    Curr Atheroscler Rep; 2020 Jan; 22(2):2. PubMed ID: 31912380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):165-74. PubMed ID: 23489530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.
    Capoulade R; Côté N; Mathieu P; Chan KL; Clavel MA; Dumesnil JG; Teo KK; Tam JW; Fournier D; Després JP; Pibarot P;
    Can J Cardiol; 2014 Sep; 30(9):1088-95. PubMed ID: 25015689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study.
    Clavel MA; Messika-Zeitoun D; Pibarot P; Aggarwal SR; Malouf J; Araoz PA; Michelena HI; Cueff C; Larose E; Capoulade R; Vahanian A; Enriquez-Sarano M
    J Am Coll Cardiol; 2013 Dec; 62(24):2329-38. PubMed ID: 24076528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis.
    Capoulade R; Torzewski M; Mayr M; Chan KL; Mathieu P; Bossé Y; Dumesnil JG; Tam J; Teo KK; Burnap SA; Schmid J; Gobel N; Franke UFW; Sanchez A; Witztum JL; Yang X; Yeang C; Arsenault B; Després JP; Pibarot P; Tsimikas S
    Heart; 2020 May; 106(10):738-745. PubMed ID: 32054669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age and aortic valve anatomy on calcification and haemodynamic severity of aortic stenosis.
    Shen M; Tastet L; Capoulade R; Larose É; Bédard É; Arsenault M; Chetaille P; Dumesnil JG; Mathieu P; Clavel MA; Pibarot P
    Heart; 2017 Jan; 103(1):32-39. PubMed ID: 27504001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between lipoprotein-associated phospholipase A
    Zhou F; Liu Y; Shi H; Huang Q; Zhou J
    Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.